Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia
NIJMEGEN, The Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, a…
Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by…
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
March 20, 2025 17:35 ET | Source: vTv Therapeutics Inc. Clinical hold…
Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer
March 19, 2025 04:00 ET | Source: Oxford BioTherapeutics Collaboration leverages OBT’s…
Cellphire Therapeutics CLPH-511 Fast Track Designation Granted
FDA has granted CLPH-511 Fast Track Designation for the treatment of acute…
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
March 17, 2025 09:25 ET | Source: Capricor Therapeutics --Preservation of Skeletal…
Skyhawk Therapeutics Presents at Huntington’s Disease Youth Organization HDYO International Congress 2025
Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator…
Registration Is Now Open For Tribe Publics Webinar Event Keys To The Kingdom: Unlocking The Power Of Your Immune System Featuring Indaptus Therapeutics CEOOn Monday, March 17, 2025
Meet with Indaptus Therapeutics’ CEO Jeffrey MecklerRegister at INDP-KEYS.TribePublic.com NEW YORK, March…
Mineralys Therapeutics Announces Pricing of $175.0 Million Underwritten Public Offering of Common Stock
March 11, 2025 22:20 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…
Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference
March 10, 2025 07:00 ET | Source: AVACTA GROUP PLC LONDON and…